期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重症肌无力患者伴胸腺增生及胸腺瘤的电生理特点分析 被引量：1

下载PDF
导出
摘要 目的研究重症肌无力伴胸腺增生及胸腺瘤患者的神经电生理特点。方法回顾性分析12例重症肌无力伴胸腺增生及胸腺瘤患者的重复电刺激(RNs)资料。结果重症肌无力伴胸腺增生及胸腺瘤患者面神经、腋神经和尺神经检测的阳性率均明显高于胸腺正常组,进一步比较胸腺异常组面神经RNS阳性率高于胸腺正常组,差异有统计学意义(P<0.05),腋神经和尺神经RNS阳性率在两组间无差异(P>0.05)。两种病理类型中低频RNS阳性率均显示出从高到低的电生理特点,依次为腋神经>面神经>尺神经。结论重症肌无力伴胸腺增生及胸腺瘤患者,R面神经RNS阳性率高于胸腺正常MG患者;MG患者腋神经和尺神经RNS阳性率,在胸腺正常和异常组之间是相近的。
作者 闫晓海
机构地区 河南省安阳地区医院
出处 《中国实用医药》 2011年第2期114-115,共2页 China Practical Medicine
关键词 重症肌无力 胸腺增生 胸腺瘤 电生理学
分类号 R746.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献4

二级参考文献17

  • 1李罗清,孙圣刚,曹学兵,徐金枝,杨明山,常丽英,殷小平.糖皮质激素对重症肌无力患者白细胞介素-6和乙酰胆碱受体抗体的影响(英文)[J].中国现代医学杂志,2004,14(19):42-45. 被引量：4
  • 2Lanska DJ. Indications for thymectomy in myasthenia gravis. Neurology, 1990, 40(12):1828.
  • 3Sitzer G, Brune GG. Effect of cholinesterase inhibitors and thymectomy on single - fiber EMG in myasthenia gravis. Ann NY Acad Sci,1981,377(8):884.
  • 4Gronseth S, Barohn RJ. Practice parameters: thymectomy for autoimmune myasthenia gravis (an evidence base review ). Neurology,2000, 55(1):7.
  • 5Jaretzki Ⅲ A, Steinglass KM, Sonett JR. Thymectomy in the management of myasthenia gravis. Seminars in Neurology, 2004,24(1):49.
  • 6Liu Wei, Tong Ti, Ji ZhengDong, et al. Long - term prognostic analysis of thymectomized patients with myasthenia gravis. Chinese Medical Journal, 2002,115(2): 235.
  • 7许贤豪.重症肌无力[M]//许贤豪主编.肌无力-临床与基础.北京:中国协和医科大学出版社,2003:46-75.
  • 8YOUNGER DS,RAKSADAWAN N.Medical therapies in myasthenia gravis[J].Chest Surg Clin N,2001,11(2):329-336.
  • 9RICHMAN DP,AGIUS MA.Treatment of autoimmune myasthenia gravis[J].Neurology,2004,63(6):1138-1139.
  • 10MONDEN Y,NAKAHARA K,FUJII Y,et al.Myasthenia gravis in elderly patients[J].Ann Thorac Surg,1985,39(5):433-436.

共引文献27

同被引文献15

  • 1Tackenberg B, Kruth J, Bartholomaeus JE, et al. Clonal expansions of CD4 + B helper T cells in autoimmune myasthenia gravis [ J ]. Eur J Immunol, 2007,37 ( 3 ) : 849.
  • 2Prelog M, Keller M,Geiger R, et al. Thymeetomy in early childhood:significant alterations of the CD4( + )CD45RA ( + )CD62L( + ) T cell compartment in later life[J]. Clin Immunol,2009,130 ( 2 ) : 123.
  • 3Sakthivel P, Ramanujam R, Wang XB,et al. Programmed death-1 : from gene to protein in autoimmune human myasthenia gravis [ J ]. J Neuroimmunol, 2008,193 ( 1/2 ) : 149.
  • 4Aricha R, Feferman T, Fuchs S, et al. Ex vivo generated regulatory T cells modulate experimental autoimmune myasthenia gravis[ J]. J Immunol,2008,180(4) :2132.
  • 5Keir ME, Butte M J, Freeman GJ, et al. PD-1 and its ligands in tolerance and immunity [ J ]. Annu Rev Immunol, 2008, 26 : 677.
  • 6Afaneh C, Muthukumar T, Lubetzky M, et al. Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1 or PD-L2 and acute rejection of human renal allografts [ J ]. Transplantation, 2010, 90(12) : 1381.
  • 7Mu CY,Huang JA, Chen Y, et al. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cell immune escape through suppressing tumor infiltrating dendritic cells maturation[J]. Med Oncol,2011,28(3) :682.
  • 8Geng L, Deng J, Jiang G, et al. B7-H1 up-regulated expression in human hepatocellular carcinoma tissue:correlation with tumor interleukin-10 levels [ J ]. Hepatogastroenterology, 2011, 58 (107/108):960.
  • 9Frigola X, Inman BA, Lohse CM, et al. Identification of a soluble form of BT-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma [J]. Clin Cancer Res, 2011, 17 (7) : 1915.
  • 10Jia R, Jiao Z, Xu X, et al. Functional significance of B7-H1 expressed by human uveal melanoma cells [ J ]. Mol Med Report,2011,4( 1 ) :163.

引证文献1

中国实用医药
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部